Pelvic cancer registry for online adapted radiotherapy
Part of Cancer clinical trials.
This study collects data from patients receiving a type of radiation therapy that is adjusted in real-time. It aims to learn more about how well this approach works for pelvic and chest tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a tumor in the pelvis or chest that needs radiation therapy
- You are 18 years old or older
- You understand the study and agree to take part in it
- You have not had radiation therapy to the same area before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give radiation therapy for tumors in the belly or pelvis. Doctors will use daily MRI scans to adjust the radiation dose, aiming to better protect nearby organs while still treating the cancer.
This trial tests a personalized radiation therapy approach for gynecological tumors. It aims to improve treatment by adapting the radiation plan based on changes in the tumor and nearby organs during your therapy course.
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
This trial tests a type of radiation that adapts to your body changes during treatment for cervical cancer. It aims to improve accuracy and reduce side effects.
This trial tests a new radiation therapy machine that adjusts the radiation plan in real-time based on changes in your body. It may help make treatment more precise and reduce side effects.
This registry collects information from people who have conditions that may be treated with radiation therapy (proton or standard X-ray radiation). It helps the clinic better understand patients’ care and outcomes, and joining requires signing consent.
Hear when a new Pelvic Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.